BIONOMOUS announces today it has raised a CHF 1.3 million Seed funding round led by Nivalis Group, with participation from SICTIC business angels and Venture Kick.
Since we founded Bionomous in 2019 it has been a challenging and exciting pathway to get where we are today. The closing of this Seed funding round is a huge milestone for our company. This fresh investment will allow us to accelerate the testing phase of the EggSorter, to develop a certified product ready-for-market, and to prepare for industrialization.
The investment from Nivalis Group marks the start of a new development phase for Bionomous. Nivalis Group CEO Nicolas Corsi explains why they have taken an interest:
For the SICTIC investors, the reasons to invest are clear. In the words of Marcel Egger, lead SICTIC investor:
On our side, we believe that this milestone would not have been possible without the amazing team that we have. Thanks to our team work we have been able to develop a product that allows to increase research throughput and standardize processes in the Life Science industry and that can be adjusted to each of our client specific needs. Frank Bonnet, Bionomous CEO & Co-founder explains:
Furthermore, this Seed funding round will allow us to explore the possibilities to apply our technology to other segments in the industry, Bionomous CMO & Co-founder Ana Hernando adds:
Read the official press release below.